Tsang, Tiffany
Posimo, Jessica M.
Gudiel, Andrea A.
Cicchini, Michelle
Feldser, David M. http://orcid.org/0000-0001-5975-864X
Brady, Donita C. http://orcid.org/0000-0002-2786-2802
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31CA243294, RO1CA193603, RO1CA222503)
American Cancer Society (131203 PF 17 147 01 CCG)
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (T32ES019851)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM124749)
Pew Charitable Trusts (#50359)
V Foundation for Cancer Research (3C59 8ABS 3424 3BDA)
Article History
Received: 21 September 2018
Accepted: 5 February 2020
First Online: 16 March 2020
Competing interests
: D.C.B. holds ownership in Merlon Inc. D.C.B. is an inventor on the patent application US 20150017261 entitled “Methods of treating and preventing cancer by disrupting the binding of copper in the MAP kinase pathway”. The other authors declare no competing interests.